Literature DB >> 10494286

Bladder. Risk and prognostic factors--a pathologist's perspective.

V E Reuter1.   

Abstract

Morphology remains a power tool to help predict the risk of recurrence, progression, and even response to therapy in bladder cancer. Nevertheless, more work is needed to refine and standardize criteria and terminology. Novel molecular tools may reveal prognostic factors, but these techniques must be compared with standard morphologic and clinical markers by performing multivariate analysis in a prospective fashion.

Entities:  

Mesh：

Year:  1999        PMID： 10494286     DOI： 10.1016/s0094-0143(05)70196-8

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  7 in total

1.  Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.

Authors:  J W A Oosterhuis; R F M Schapers; M L G Janssen-Heijnen; R P E Pauwels; D W Newling; F ten Kate
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Profile of lesions in cystoscopic bladder biopsies: a histopathological study.

Authors:  Raghuveer C V; Sanjay Hingle
Journal:  J Clin Diagn Res       Date:  2013-08-01

3.  UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer.

Authors:  Guo-Liang Yang; Lian-Hua Zhang; Juan-Jie Bo; Hai-Ge Chen; Ming Cao; Dong-Ming Liu; Yi-Ran Huang
Journal:  Med Oncol       Date:  2011-05-25       Impact factor: 3.064

Review 4.  Grading Systems for Canine Urothelial Carcinoma of the Bladder: A Comparative Overview.

Authors:  Eleonora Brambilla; Veronica M Govoni; Alexandre Matheus Baesso Cavalca; Renée Laufer-Amorim; Carlos Eduardo Fonseca-Alves; Valeria Grieco
Journal:  Animals (Basel)       Date:  2022-06-04       Impact factor: 3.231

5.  A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer.

Authors:  Yann Neuzillet; Xavier Paoletti; Slah Ouerhani; Pierre Mongiat-Artus; Hany Soliman; Hugues de The; Mathilde Sibony; Yves Denoux; Vincent Molinie; Aurélie Herault; May-Linda Lepage; Pascale Maille; Audrey Renou; Dimitri Vordos; Claude-Clément Abbou; Ashraf Bakkar; Bernard Asselain; Nadia Kourda; Amel El Gaaied; Karen Leroy; Agnès Laplanche; Simone Benhamou; Thierry Lebret; Yves Allory; François Radvanyi
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

6.  Epigenetic inactivation of ST6GAL1 in human bladder cancer.

Authors:  Pia Antony; Michael Rose; Axel Heidenreich; Ruth Knüchel; Nadine T Gaisa; Edgar Dahl
Journal:  BMC Cancer       Date:  2014-12-02       Impact factor: 4.430

7.  The Role of Computerized Tomography in the Assessment of Perivesical Invasion in Bladder Cancer.

Authors:  Ibrahim Ilker Oz; Namik Kemal Altinbas; Ismail Serifoglu; Evrim Bozay Oz; Cemil Yagci
Journal:  Pol J Radiol       Date:  2016-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.